Uncovering Hidden Causes: Nontraditional Risk Factors Illuminate Unexplained Strokes in Adults Under 50

In a groundbreaking new study published in the prestigious journal Stroke, researchers have unveiled compelling evidence that young adults under the age of 50 who suffer cryptogenic ischemic strokes—strokes without an identifiable traditional cause—are far more likely to have their events linked to nontraditional risk factors than previously understood. This research shifts the focus away from classic stroke contributors such as hypertension and diabetes, highlighting instead conditions like migraine with aura, liver disease, and cancer, which were found to substantially increase stroke risk, particularly among individuals with a patent foramen ovale (PFO), a small, normally benign cardiac defect.

The patent foramen ovale is a persistent opening between the heart’s upper chambers that typically closes shortly after birth, but remains open in approximately 25% of the general population. While generally asymptomatic, this anatomical quirk has long been associated with an elevated risk of cryptogenic stroke, though its exact mechanistic role has been elusive. The new findings from the European multi-center SECRETO study provide clarity by dissecting how varying stroke risk profiles interplay with the presence or absence of a PFO, offering a nuanced understanding of stroke pathology in younger demographics.

The study analyzed a robust dataset encompassing over 1,000 adults aged 18 to 49, evenly split between those who had experienced a cryptogenic ischemic stroke and matched controls who had never suffered a stroke. Importantly, the median participant age was 41, and slightly less than half were female, allowing for a balanced exploration of sex-specific risk factors. Investigators meticulously examined a broad range of 12 traditional risk determinants—including hypertension, smoking, obesity, and Type 2 diabetes—and contrasted these with 10 nontraditional factors such as migraine with aura, chronic liver disease, chronic kidney disease, venous thromboembolism, and malignancy. Additionally, five female-specific risk factors, including gestational diabetes and pregnancy complications, were evaluated for their contribution to stroke incidence.

One of the study’s most striking revelations is the predominance of nontraditional risk factors among those with a PFO. The risk conferred by traditional factors was markedly attenuated in this subgroup; each traditional risk factor only modestly raised stroke risk by 18%. Conversely, nontraditional factors more than doubled the odds of ischemic stroke in participants harboring a PFO after adjustments for age, sex, and education level. This contrasts sharply with stroke cases lacking a PFO, where traditional risk factors retained a dominant influence, accounting for approximately 65% of stroke risk, compared to 27% attributed to nontraditional risks.

Delving deeper, migraine with aura emerged as the most potent nontraditional risk factor associated with cryptogenic stroke. Among individuals with a PFO, migraine with aura accounted for nearly half of the attributable risk for stroke, while its contribution was significant but lower for those without the heart defect. This finding aligns with previous clinical observations linking migraine aura to stroke risk but suggests a mechanistic interaction facilitated by the right-to-left shunting of emboli through the PFO, rendering migraine sufferers particularly vulnerable.

The study also illuminates the critical role of sex-specific factors in shaping stroke risk profiles. Women, especially younger women, bore an outsized burden from risk factors unique to their physiology, such as pregnancy-related complications. These female-specific risks independently increased the likelihood of stroke by 70% regardless of other traditional or nontraditional factors. This highlights a pressing need for clinicians to incorporate reproductive and hormonal histories into stroke risk assessments and prevention strategies for younger women.

Traditional risk factors, while often the primary focus of stroke prevention programs, were found to have differential impacts depending on the presence of the PFO. In participants without the heart defect, each additional traditional risk factor—like high blood pressure or smoking—was linked to a 41% increase in stroke risk. This robust association reinforces the importance of managing established vascular risk profiles. However, the research underscores that traditional risk models may not be sufficient for assessing stroke risk in all young individuals, especially those with underlying cardiac anomalies.

Importantly, the study acknowledges significant limitations. As an observational analysis harnessing data from the SECRETO cohort, its retrospective design precludes definitive causal inferences. The reliance on self-reported data for risk factors such as migraine and comorbidities could introduce reporting bias. Moreover, the predominantly European descent of participants (95%) restricts the generalizability of findings to more ethnically diverse populations, necessitating further research in varied demographic settings.

This research marks a pivotal step in understanding the heterogeneous nature of cryptogenic strokes in the young. The refined characterization of risk stratification based on PFO status and the delineation of nontraditional contributors calls for a paradigm shift in clinical practice: stroke prevention strategies must evolve to include routine screening for migraine with aura and other unconventional risks, particularly in patients exhibiting the PFO. Tailored approaches that integrate cardiac imaging and comprehensive risk factor profiling could significantly enhance secondary prevention and reduce recurrent stroke incidence in this vulnerable group.

Moreover, these findings elevate the importance of interdisciplinary collaboration between neurologists, cardiologists, and primary care providers. The intricate interplay of migraine, cardiac anomalies, and non-traditional vascular risks demands a holistic evaluation beyond standard cardiovascular risk assessments. Early identification and management of these risk factors may offer a unique opportunity to mitigate stroke risk in younger adults who might otherwise evade conventional screening parameters.

While recognizing that further prospective studies are essential to validate these associations and elucidate pathophysiological mechanisms, this study provides a robust foundation for future investigations. Insights into the biological underpinnings linking migraine aura and PFO to embolic stroke could lead to novel therapeutics targeting these pathways. It also shines a spotlight on underappreciated contributors to stroke risk that deserve greater clinical attention and research investment.

Clinicians and public health professionals should heed these revelations by incorporating migraine and other nontraditional risks into patient interviews and diagnostic workflows, especially when evaluating younger adults presenting with ischemic strokes lacking clear etiology. Enhanced awareness and education around PFO-associated risks may prompt more judicious use of interventions, such as percutaneous closure of PFOs, and refined preventive care tailored to each patient’s unique risk landscape.

In conclusion, the SECRETO study fundamentally challenges the traditional stroke risk model in young adults by delineating a complex risk matrix influenced heavily by nontraditional factors in the context of patent foramen ovale. This paradigm shift holds significant potential to improve outcomes through personalized medicine approaches and underscores the necessity of widening our investigative lens when approaching cryptogenic ischemic strokes in the young.

Subject of Research: Cryptogenic ischemic stroke risk factors in young adults linked to patent foramen ovale

Article Title: Burden of Modifiable Risk Factors in Young-Onset Cryptogenic Ischemic Stroke by High-Risk Patent Foramen Ovale

News Publication Date: April 17, 2025

Web References:

https://www.stroke.org/en/about-stroke/types-of-stroke/ischemic-stroke-clots
https://www.stroke.org/en/about-stroke/types-of-stroke/cryptogenic-stroke
https://www.heart.org/en/health-topics/congenital-heart-defects/about-congenital-heart-defects/patent-foramen-ovale-pfo
https://www.ahajournals.org/doi/10.1161/STROKEAHA.124.049855

References:

Putaala J., et al. Burden of Modifiable Risk Factors in Young-Onset Cryptogenic Ischemic Stroke by High-Risk Patent Foramen Ovale. Stroke. 2025. DOI: 10.1161/STROKEAHA.124.049855

Keywords: Cryptogenic stroke, patent foramen ovale (PFO), migraine with aura, ischemic stroke, young adults, stroke risk factors, nontraditional risk factors, sex-specific risks, stroke prevention, cardiovascular anomalies, stroke epidemiology

Tags: cancer as a stroke risk factorcardiovascular anomalies and strokecryptogenic ischemic strokesemerging stroke risk profilesliver disease and ischemic strokemigraine with aura and stroke risknontraditional stroke risk factorspatent foramen ovale and strokeSECRETO study findingsstroke pathology in young adultsunexplained strokes in under 50syoung adults stroke research